Profil
Paul D.
Rubin formerly worked at Critical Therapeutics, Inc., as President & Chief Executive Officer from 2002 to 2007, Resolvyx Pharmaceuticals, Inc., as President & Chief Executive Officer from 2007 to 2009, Abbott Laboratories, as Vice President-Immunology & Endocrinology from 1987 to 1993, Sumitomo Pharma America, Inc., as Executive Vice President-Research & Development from 1996 to 2002, XOMA Corp., as Chief Medical Officer, SVP-Research & Development from 2012 to 2016, Funxional Therapeutics Ltd., as Chief Medical Officer in 2011, GlaxoSmithKline LLC, as Vice President-Worldwide Clinical Pharmacology from 1993 to 1996, and Viridian Therapeutics, Inc., as Executive Vice President-Research & Development from 2017 to 2019.
Dr. Rubin received his undergraduate degree from Occidental College and doctorate degree from Rush Medical College.
Anciens postes connus de Paul D. Rubin
| Sociétés | Poste | Fin |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/12/2019 |
| XOMA CORPORATION | Directeur Technique/Scientifique/R&D | 18/11/2016 |
Funxional Therapeutics Ltd.
 Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Funxional Therapeutics Ltd. is a clinical stage pharmaceutical company, which offers drug and therapeutic development programs. It specializes on anti-inflammatory therapies and compounds. The company was founded by David J. Grainger on August 8, 2011 and is headquartered in Cambridge, the United Kingdom. | Directeur Technique/Scientifique/R&D | 01/06/2011 |
Resolvyx Pharmaceuticals, Inc.
 Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | President | 01/01/2009 |
| Critical Therapeutics, Inc. | Directeur Général | 01/01/2007 |
Formation de Paul D. Rubin
| Occidental College | Undergraduate Degree |
| Rush Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| XOMA CORPORATION | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Critical Therapeutics, Inc. | Health Technology |
Resolvyx Pharmaceuticals, Inc.
Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Funxional Therapeutics Ltd.
Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Funxional Therapeutics Ltd. is a clinical stage pharmaceutical company, which offers drug and therapeutic development programs. It specializes on anti-inflammatory therapies and compounds. The company was founded by David J. Grainger on August 8, 2011 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |